Objective. 
INTRODUCTION
Atherosclerosis represents a large-arteries disease in which lipoproteins are accumulated within the arterial wall (1, 2) . Atherogenic molecules, such as low-density lipoprotein (LDL) play an important role in the development of atherosclerosis (3) . Except LDL, which is the crucial factor for atherosclerosis, many other parameters have also been established as important. These include wall thickness, wall composition, transmural pressure etc., however, it has not been clearly determined which of them has the highest impact (3) (4) (5) (6) (7) (8) . Increased permeability of LDL in endothelium has been reported in some earlier research studies done on hypertensive animals (9, 10) . There are some indications that hypertension enhances LDL entry into the intima by changing the permeability of the endothelium (9, 10) . Previous in vitro studies indicated that stretching of the arterial wall induced by pressure is the major factor of LDL accumulation in atherosclerotic disease and the other mass transport into the arterial wall, especially in the inner section of the vessel (4, 11, 12 ORIGINAL SCIENTIFIC ARTICLE that LDL transendothelial transport is predominantly determined by the leaky junctions pathway. All previous studies which aimed to explain the mechanisms of LDL transport and accumulation in the blood vessel wall were performed either on isolated blood vessel segments without dynamic flow and shear-stress conditions (11, 13, 14) or in vitro using cultured endothelial cell mono-layers (4) or they were performed by using mathematical and computational models of blood vessels (3, 15, 16) . keeping all this in mind, we researched the LDL uptake (transport) into the blood vessel wall, under physiologically relevant constant pressure and perfusion flow (more similar to in vivo conditions), in the isolated rabbit carotid artery. Moreover, what we wanted to evaluate was a new method which could be used to determine LDL transport into blood vessel wall.
MATERIAL AND METHODS
Ex vivo blood vessels experiments were performed on the isolated rabbit left and right common carotid artery. All experiments were performed in accordance with the Animals Scientific Procedures Act 1986 (uk) and Local Ethical Guidelines.
Blood vessel preparation
New Zealand White rabbits of both sexes (n=5) weighing 3.5-4 kg were anesthetized by using sodium pentobarbital (0.5 mg/kg of body weight, i.v.) and ketamine (0.5 mg/kg of body weight) (Laboratory Sanderson, Santiago, Chile) (17) . Blood vessel was excised and placed in the water bath. Cannulas with equally matched tip diameters (2 mm) were mounted at proximal (cardiac) and distal (cranial) ends of the blood vessel and the lumen was perfused with krebs-Ringer physiological solution (kRS), using the peristaltic pump at 1 mL/min. The perfusate was continuously bubbled with a 95% O2 and 5% CO2, with the pH adjusted to 7.4 at 37°C. The blood vessel was stretched to its approximate in vivo length. The distal cannula was connected to the resistance changing device and perfusion pressure was measured by using pressure transducer. The blood vessel was considered viable if it contracted when 25 mM kCl was added to the bath, as well as if the presence of functional endothelium was verified by dilation with Ach (1 µM) at the end of experiment.
Rapid dual -isotope dilution method
This method measures the relative extraction (uptake) of the test molecule ( 125 I-LDL) in relation to an extracellular referent tracer ( 99m Tc-Nanocis, EBD) as it transits through the blood vessel (18, 19 Tc-Nanocis ). The first 15 samples (3 drops in each sample) and 9 cumulative 3 min samples of perfusion effluent were sequentially collected. The first 15 samples were prepared for measurement of tracer concentration by adding physiological buffer until the final volume of 3 mL/sample. Tracer concentration in the cumulative samples was estimated without dilution. EBD concentration in each sample, as well as in the three standard EBD solutions, was estimated by measuring the absorbance value (Micro-sample spectrophotometer, Gilford Instrument). The absorbance intensity is proportional to EBD concentration which is used to obtain perfusion concentration-time curves, i.e. dilution profiles for Evans Blue Dye. Measurements of perfusion effluent samples containing 99m Tc-Nanocis were performed by means of gamma counter (Wallac Wizard 1400). The radioactivity of isotope in the perfusion effluent samples (as a percentage of the injected dose) was plotted against the collection time, in order to obtain radioactivity-time curves, i.e. dilution profiles for the investigated molecule.
All control experiments were performed by using the plastic tube instead of the blood vessel under the experimental conditions: constant flow of 1, 2, 3 mL/min.; perfusion pressure of 100, 130, 160, 190 mmHg; medium temperature of 37ºC. We have performed the following activities using the plastic tube instead of the blood vessel to determine: a) The correction factors for the dilution profiles of potential referent tracers (EBD,   99m Tc-Nanocis); b) The optimal radioactivity for the test tracers ( 125 I-LDL) in the infusion bolus that is sufficient to produce detectable dilution profiles.
Mathematical analysis of dilution profiles

Experimentally obtained dilution profiles for EBD and 99m
Tc-Nanocis are presented in Figure 1 . In this figure we present the fitted values of experimentally obtained data. Both curves were fitted (R 2 ≥0.98) by means of the following equation: (Eq. 1) where y is percent of recovered dose, and x is time (in seconds).
It is obvious from the figure 1 that the maximal recovered doses of EBD and 99m Tc-Nanocis do not appear at the same time indicating different convective diffusion properties of those two molecules. Thus, direct mathematical evaluation of the test tracer uptake could not be possible without the correction of dilution profiles for that difference. By dividing EBD dilution profile by 99m Tc-Nanocis dilution profile corresponding values, we obtained corrective factors by which 99m Tc-Nanocis dilution profile has to be multiplied (for each time period) to achieve the full overlap of those dilution profiles. This overlap is supposed to occur due to both traces' injection into the plastic tube (instead of the blood vessel), so the full recovery in each time interval is positively supposed (no uptake for both tracers). In that way, 99m Tc-Nanocis can be used as a referent tracer; no matter if convective diffusion difference does exist.
Even EBD dilution profiles obtained from the experiments performed in the plastic tube show almost full overlap with 125 I-LDL dilution profiles, the 99m Tc-Nanocis was used as referent tracer in further investigations, because EBD can pass the endothelial barrier if it is not absolutely intact.
125 I-LDL (test tracer) and 99m
Tc-Nanocis (referent tracer) dilution profiles in the isolated blood vessels.
Rapid dual-isotope dilution method for 125 I-LDL (test tracer) and Tc-Nanocis (referent tracer) was performed as described above (Section 2.2). Measurements of perfusion effluent samples containing 125 I-LDL were performed by means of the gamma counter (Wallac Wizard 1400). The 125 I-LDL uptake (us %) is derived from the difference between the 99m Tc-Nanocis value and that of 125 I-LDL recovery in each sample.
Steady state method
The isolated blood vessel was placed into the water bath with physiological buffer. After the equilibration period (20-30 min) at constant perfusion flow of 1 mL/min Resistance changing device was applied to achieve a constant perfusion pressure (70 ± 10 and 140 ± 10 mmHg). When target pressure was achieved, the period of equilibration (15-30 min) was allowed. Then, the 125I-LDL standard solution (100 μL/min) was continuously injected into the blood vessel (inflow dose), using rapid infusion pump for 10 minutes. Automatic sampler that allows precise and automatic collection of samples was used to continuously collect the first 12 samples (cumulative 1 min samples of perfusion effluent) and 6 cumulative 3 min samples. The radioactivity in each sample represents the outflow dose in corresponding time period. The first 12 samples were prepared for measurement of 125 I-LDL specific activity by adding physiological buffer until the final volume of 3 mL/sample.
125
I-LDL specific activity in the 3 min cumulative samples was estimated without 125 I-LDL dilution. After sampling, the blood vessel was cut onto 3 segments (proximal -cardiac , medial and distal -cranial) and the radioactivity accumulation of the 125 I-LDL in the wall was measured in each segment with gamma counter (Wallac Wizard 1400).
125I-LDL dilution profiles
125 I-LDL specific activity in each sample was measured with gamma counter (Wallac Wizard 1400). 125 I-LDL specific activity in each sample was used to obtain radioactivity -time curves, i.e. dilution profiles for 125 I-LDL during its flow through blood vessel at constant perfusion pressure.
125 I-LDL specific activity in the first 10 samples during the inflow period was used for the creation of the dilution profile curve ( figure 2 and 4) . The 125 I-LDL specific activity in the 11th and 12th sample as well as in the next 6 of 3 min cumulative samples was used to create the dilution profile curve for the radioactivity recovery in the washout period (figure 2 
Mathematical analyses of dilution profiles
Experimentally obtained dilution profile curves within the inflow period were fitted by using the following exponential equation (20) :
y=α(1-e -bx ) (Eq. 2) where y is the specific radioactivity (cpm) and x has time units (min). Also, a and b are the coefficients of this relation and a has radioactivity units (cpm) and b has time units (1/min).
This function is shown in figure 3 as the radioactivity vs. time curve. The constant a represents the maximum developed radioactivity, i.e. the radioactivity corresponding to the steady state period.
We introduce a dominant time constant (T) as the time value corresponding to the cross section point between the asymptote of the exponential curve and the tangent of the exponential curve at the zero point. This constant follows from the function: T=1/b
We consider that the alternate steady state is reached for t = 5T (t = time), because in this case e -t/T =e -5 » 0, and y» a.
Experimentally obtained dilution profile curves within the washout period were fitted by using the following exponential equation:
y=ae -bx (Eq. 3) where y is the specific radioactivity (cpm) and x is the time (min). Also, a and b are the coefficients of this relation. The coefficient is the same in the Eq. 3 and Eq. 2.
We consider that the radioactivity values approaches the zero for -bx=-5, because in this case e -bx =e -5 » 0, and y» 0.
Experimentally obtained dilution profile curve within the inflow period fitted using Eq. 2 is shown in figure 4 .
The steady state uptake was calculated as a difference between the inflow dose of 125 I-LDL and the outflow dose (in samples) within the period of the steady state.
Endothelium removal procedure
125 I-LDL uptake was evaluated before and after the perfusion with deoxycholic acid. After blood vessel had been prepared as previously described (see section above) Resistance changing device was applied to achieve a constant perfusion pressure (60 ± 10 mmHg). When the target pressure was achieved, the period of equilibration (15-30 min) was allowed. Then, the deoxycholic acid was continuously injected (100 L/min) into the blood vessel by using syringe infusion pump (Sage instruments, Inc., uSA) for 3 minutes in order to chemically remove the endothelium (21, 22, 23) . The final concentration of deoxycholic acid in the perfusion solution was 2.5 mM. After the recovery period (about 15 min) the 125I-LDL standard solution (100 μL/min) was continuously injected into the blood vessel (inflow dose), by using rapid infusion pump for 10 minutes. Samples were collected and measured as described above.
Reagents
The composition of krebs-Ringer physiological solution contained (in mM): NaCl 117, kCl 4.7, NaHCO3 24.8, MgSO4 x7H2O 1.2, CaCl2 2.5, kH2PO4 1.2 and Dglucose 11.1 (Merck, Darmstadt, Germany). Evans Blue Dye solution contained 0.33 mg EBD per ml of H2O distillated. Tc-Nanocis is rhenium sulfide nanocolloid (CIS Bio International, France) in which 95% of the particles were between 8 and 68nm, approximately (mean around 23-25nm with water for injection until 2 ml.
125 I-Low density lipoprotein (Biomedical Technologies Inc, uSA, Catalogue no. BT-903); specific activity: 0.102μCi/ml; quantity: 525 μCi/2ml.
Statistical analysis
Paired t -test with the significance threshold of p<0.05 was used for statistical comparisons of data between us under different pressures. All statistical calculations were done with the computer program SPSS, version 13.0. Data are presented as mean ± standard error (SE).
RESULTS
Rapid dual -isotope dilution method
We determined the dilution profiles for 125 I-LDL and 99m
Tc-Nanocis using Rapid dual-isotope dilution method at the pressure of 10, 80 and 140 mmHg, in the blood vessel segment during one passing (100 L bolus injection) of the tracers. These profiles showed the logarithmic normal distribution (Eq. 1) and were shifted to the left from the higher to the lower values of the pressure. Our results showed that there was no statistically significant difference between dilution profiles for 99m TcNanocis and 125 I-LDL, suggesting that the transport of 125 I-LDL could not be precisely determined in this way because it was in the range of the standard error. Also, we measured the accumulation of the 125 I-LDL in each segment. These results showed that at 10 mmHg there was no radioactivity in any segment; at 80 mmHg 0.02% radioactivity of the total injected dose was measured only in the cranial segment and at 140 mmHg 0.05% of the injected dose was measured in the cranial segment, 0.02% in the medial and 0.01% in the cardiac segment According to these results, the blood vessel wall uptake of 125 I-LDL has very low capacity and is extremely slow. Due to these experimental results, we decided to change the protocol and the continuous 10 minutes perfusion of the 125 I-LDL was applied (steady state method).
Steady state method
The experimental data were analyzed by using a method described in the previous section and the results are shown in table 1.
When lower pressure was applied (70 ± 10 mmHg), by increasing intravascular resistance by using resistance changing device at the end of cranial cannula, corresponding us (steady state uptake) of 125 I-LDL was within the value of standard error (± 1.3%) and not detectable. The value of b coefficient, of the fitted experimental data (Eq 2), which describes the dynamics of 125 I-LDL passage through the blood vessel wall, was 2.5 ± 0.08 and 5T parameter (the time within which the steady state was achieved) was 3.33 ± 0.4 min. Furthermore, our results showed that at the higher perfusion pressure (140 ± 10 mmHg) calculated us was 3.52 ± 1.07, b coefficient was 1.25 ± 0.03 and 5T was 4 ± 0.6 min. These results are statistically significant when compared to the results obtained at lower pressure (p < 0.05).
After sampling, the blood vessel was cut into 3 segments and radioactivity accumulation of the 125 I-LDL in the blood vessel wall was measured in each segment with gamma counter (Wallac Wizard 1400). Our results showed that accumulation of the 125 I-LDL in the blood vessel wall was 0.06 ± 0.03 (% of the inflow dose). Also, our results showed that the most 125 I-LDL radioactivity was in the cranial and the least in the cardiac blood vessel segment (table 2) .
According to these results, the intact endothelium is a strong barrier for the LDL uptake by the blood vessel wall, allowing only a low accumulation of LDL. It means that under physiological conditions we cannot expect any accumulation of LDL in the blood vessel wall. That is why we decided to remove the endothelium to clarify the influence of endothelium damage on the LDL uptake by the blood vessel wall.
Endothelium removal
The LDL uptake by the blood vessel wall under Steady state condition was investigated on the isolated blood vessel segment with the removed endothelium. Endothelium removal procedure was described in the previous section. Our preliminary results suggest that: -us was 9.2%; -accumulation of the LDL in the blood vessel wall was 0.1%; -in these experiments, unlike in all other (with intact endothelium), we detected significant radioactivity (0.4%) in the medium surrounding the blood vessel in the water bath (external side of the blood vessel). This indicates that LDL passes through the whole blood vessel wall.
DISCUSSION
Our experimental model could be used to accurately describe LDL uptake by the blood vessel wall during its passage through intravascular space. until now many studies have tried to explain the transport of LDL through the blood vessel wall and its accumulation in the wall because of its essential role in the development of atherosclerosis (3) . All of those studies were performed either on cell mono-layers (4), or on isolated blood vessel strips (13) or segments (11, 14) however without dynamic flow. That was the main reason why we decided to develop a new experimental model in which we used the isolated blood vessel segment with constant perfusion flow because the response obtained in this way is more similar to in vivo responses than in previously mentioned experiments (4, 11, 13, 14) .
First we used Rapid dual isotope method to research LDLuptake by the blood vessel wall during one passing of the radio-labeled molecules. The results obtained by using this method show that the blood vessel wall uptake of 125 I-LDL has very low capacity and slow dynamics. Due to these experimental results, the protocol has been changed and prolonged (12 minutes) and continual perfusion of 125 I-LDL molecules was applied (Steady state method). The results obtained from the Steady state method indicate very low LDL uptake by the blood vessel wall with intact endothelium which is in accordance with the results of other studies (4, 11, 13, 14, 16) . Also, our results show that at perfusion pressure of 140 ± 10 mmHg the 5T parameter value (the time within which the steady state was achieved) was higher than at 70 ± 10 mmHg, but without significant difference between two 5T parameters (p > 0.05). Lack of significant time differences within which the steady state is developed indicate that dynamics of 125 I-LDL passage through the blood vessel wall was similar at applied perfusion pressures (70 ±10 mmHg and 140 ± 10 mmHg).
Another advantage of this method is the possibility to describe dynamics of 125 I-LDL uptake by the blood vessel wall during a short period of time (seconds and minutes).
There are no literature data that describe this phenomenon in this way. up to now arteries have been incubated in the presence of radio-labeled LDL for a longer period of time (5 min, 30 min, 60 min) however without perfusion flow (13, 14) .
It has been indicated that hypertension has the impact on arterial disease susceptibility (3, 4, (6) (7) (8) and that during hypertension LDL entry into arterial wall is enhanced due to changes of endothelium permeability (9, 10) . We used different pressures in our method (0. 70 ± 10, 140 ± 10 mmHg) in order to investigate whether pressure has any contribution to LDL transport. When lower pressure was applied corresponding us was not detectable (Table 1) but after applying the higher pressure we obtained the us of 3.52 ± 1.07% which is in accordance with others (4, 10, 11, 14) . Furthermore Meyer et al. (11) showed in their study that pressure-induced wall distension unlike the pressure itself is the reason of increased endothelial permeability for macromolecules such as LDL.
According to all of these results the intact endothelium is a strong barrier for the LDL uptake by the blood vessel wall, therefore under physiological conditions with intact endothelium we cannot expect large accumulation of LDL in the blood vessel wall. Cancel et al. (4) indicated that LDL can pass through endothelium mainly through "leaky junctions" (90.9%) as its pathways, which are associated with leaky cells when they are dividing or in the state of turnover, the processes where hypertension has its role (10, 24) .
Assuming that intact endothelium is a strong barrier we decided to remove it by using deoxycholic acid. The results obtained after endothelial removal procedure showed that us of LDL was almost 3 times higher than with intact endothelium (9.2%) (p<0.05), and that accumulation of the LDL in the blood vessel wall was 0.1% (compared to 0.06 % in intact endothelium). These findings are also in accordance with the results of other studies (11, 13) .
Finally, we concluded that our experimental model together with the mathematical procedures could be used in describe precisely (with high sensitivity) the LDL uptake by the blood vessel wall during its passage through intravascular space. Further investigations are necessary in order to clarify the mechanisms underlying the LDL uptake and its contribution to better understanding of the development of atherosclerosis and its future prevention.
ABREVIATIONS
Ach -acetylcholine cpm -counts per minute EBD -Evans blue dye kRS -krebs-Ringer physiological solution
